Aflibercept-Mrbb: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Aflibercept-Mrbb. Educational only — not medical advice.
Labeled uses
1 INDICATIONS AND USAGE AHZANTIVE is indicated for the treatment of: 1.1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) 1.2 Macular Edema Following Retinal Vein Occlusion (RVO) 1.3 Diabetic Macular Edema (DME) 1.4 Diabetic Retinopathy (DR)
Source: FDA labeling via NIH DailyMed (set 289e4b90…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.